Syncor Plans to Buy Back Up to 500,000 Shares
- Share via
Syncor International Corp., a Chatsworth provider of specialized pharmaceuticals, said its board of directors authorized the repurchase of up to 500,000 shares of Syncor stock, or about 5% of its 10 million common shares outstanding. At the current stock price of about $6.50 a share, the repurchase is valued at $3.25 million.
Syncor said the stock repurchases would be funded by its ongoing cash flow and would take place occasionally on the open market.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
